BCR and neoplasm: To ascertain that the anti-tumor efficacy of scFv-OA2-siRAPSYN was resulted from the decrease of BCR-ABL neddylation and the increase of BCR-ABL degradation by the silencing of RAPSYN gene, tumor tissues in different groups of the mice were collected for various analyses.